Altor BioScience's Grant - VI Round

Altor BioScience raised a round of funding on September 28, 2012. Investors include National Cancer Institute.

Altor BioScience is a biopharmaceutical company engaged in the discovery, development and commercialization of high-value, targeted immunotherapeutic agents for the treatment of cancer, viral infectio…

Articles about Altor BioScience's Grant - VI Round: